Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of methoxyamine when given
together with fludarabine phosphate in treating patients with relapsed or refractory
hematologic malignancies. Drugs used in chemotherapy, such as methoxyamine and fludarabine
phosphate, work in different ways to stop the growth of cancer cells, either by killing the
cells or by stopping them from dividing. Giving methoxyamine together with fludarabine
phosphate may kill more cancer cells.